#2469 - Brigham Buhler

Overview

This episode dives deep into the future of healthcare, focusing on peptides, stem cells, gene therapies, and innovative approaches to preventative medicine. Brigham Buhler, founder of Ways2Well, discusses the challenges of navigating regulatory landscapes, the potential of cutting-edge treatments like MUSE stem cells, and the need for a paradigm shift from reactive sick care to proactive health optimization.

Notable Quotes

- The system is built to monetize chronic disease, not prevent it. We need to shift to proactive, predictive, and personalized care. – Brigham Buhler

- Why would I wait ten years for FDA approval if something could save my life today? – Brigham Buhler, on patient autonomy and access to experimental treatments.

- We are the wealthiest country in the world, yet the sickest. At what point do we admit this system is broken? – Joe Rogan

🧬 The Promise and Challenges of Peptides

- Peptides, naturally occurring in the body, have shown immense potential for improving health and vitality. Joe Rogan and Brigham Buhler discuss their benefits, including weight loss and healing, but also the regulatory hurdles they face.

- The FDA's reclassification of peptides as dangerous under the previous administration has stifled accessibility, despite a lack of evidence supporting safety concerns.

- Brigham highlights the lobbying power of big pharma, which views peptides as a threat to their patented drugs. He advocates for restoring peptides to the market under proper regulation to eliminate black-market risks.

🧪 Stem Cells and the Revolutionary Potential of MUSE Cells

- MUSE cells, a rare subset of stem cells, are described as super soldiers due to their ability to differentiate into any cell type and their resilience under stress.

- Unlike traditional stem cells, MUSE cells can pass through the lungs, target damaged areas, and regenerate tissue without causing tumors or immune rejection.

- Brigham shares compelling case studies, including a comatose patient showing recovery after MUSE cell treatment. He emphasizes the need for regulatory pathways to make these treatments accessible in the U.S.

💊 The Broken Healthcare System and the Case for Cash-Pay Models

- The current healthcare system prioritizes managing chronic disease symptoms over prevention, driven by insurance and pharmaceutical interests.

- Brigham argues for a cash-pay model that empowers patients to take control of their health, offering personalized care and innovative treatments outside the constraints of insurance.

- He critiques the pill mill approach of some telemedicine companies and stresses the importance of quality, patient-centered care.

🧬 Gene Sequencing and Personalized Medicine

- Gene sequencing is highlighted as a critical tool for understanding individual health risks and optimizing treatments. Brigham shares examples of how genetic insights have helped athletes like Gordon Ryan address unique health challenges.

- Future advancements could allow for gene editing to turn on beneficial traits, such as increased bone density or resistance to disease, potentially revolutionizing healthcare.

🩸 Plasmapheresis and Detoxification

- Plasmapheresis, described as an oil change for your body, removes inflammatory markers and toxins like microplastics from the blood.

- Brigham shares a success story of a patient whose testosterone levels normalized after plasmapheresis and lifestyle changes to reduce plastic exposure.

- This treatment, combined with other therapies like peptides and stem cells, offers a comprehensive approach to health optimization.